' Peter Mazereeuw’s take on the pharmacare costing analysis by the Office of the Parliamentary Budget Officer left me wondering whether we were reading the same study . Mazereeuw reports accurately that the PBO finds public universal pharmacare will deliver significant cost savings to the economy of $1.4-billion in 2024-25, rising quickly to $2.2-billion by 2027-28.
The answer is that in addition to its public health benefits, only a single-payer universal program will reduce drug and other costs, releasing funds needed urgently elsewhere in the system. Drug prices in Canada are out of control. The PBO study points out astonishingly that prescription drugs in Canada are roughly 25 per cent above the median of OECD countries. Prescription drugs consume as many public dollars as doctors’ salaries, according to the Canadian Institute for Health Information.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: SaltWire Network - 🏆 45. / 63 Read more »
Source: SaltWire Network - 🏆 45. / 63 Read more »